Adaptive Biotechnologies

129 articles with Adaptive Biotechnologies

• ASCO2016: Adaptive Biotech And Collaborators To Present Seven Studies Demonstrating The Use Of Immunosequencing To Identify Prognostic Biomarkers And Potential Biomarkers Of Response At The 2016 American Society Of Clinical Oncology Annual Meeting

  6/6/2016

• Adaptive Biotech To Present 2 Studies Demonstrating Utility Of Immunosequencing To Propel Diagnostic Development And Therapeutic Discovery At The 2016 American Association Of Immunologists Annual Meeting

  5/16/2016

• Seattle’s Adaptive Biotech Looks to Hire 50 Employees in 2016 to Buttress Fast Growth

  4/26/2016

• Adaptive Biotech And Collaborators To Present 10 Studies Demonstrating The Utility Of Immunosequencing In Both Tissue And Blood Samples At 2016 AACR Annual Meeting

  4/18/2016

• Adaptive Biotech Welcomes Charles Sang As Senior Vice President Of Diagnostics

  4/11/2016

• Seattle's Adaptive Biotech to Base New Business in San Diego with Ex-Johnson & Johnson Exec in Charge

  3/21/2016

• Innovation Leader, Diego Miralles, M.D., Joins Adaptive Biotech As President Of Adaptive Therapeutics

  3/15/2016

• Adaptive Biotech, Juno, NanoString Continue Hiring Spree in Seattle

  2/18/2016

• Pfizer Enters Into Translational Research Collaboration With Adaptive Biotech To Help Advance Novel Immuno-Oncology Solutions

  1/8/2016

• Adaptive Biotech To Present At The 34th Annual J.P. Morgan Healthcare Conference

  1/6/2016

• Adaptive Biotech’ clonoSEQ MRD Test Can Be Used To Guide Post-Transplant Treatment Decisions In Multiple Myeloma Patients

  12/7/2015

• Adaptive Biotech And Collaborators Present New Data Showing Minimal Residual Disease (MRD) Predicts Relapse And Survival In Chronic Lymphocytic Leukemia (CLL) Patients

  12/7/2015

• Adaptive Biotech And Collaborators Present New Data Demonstrating Potential Utility Of Next-Generation Sequencing Based Minimal Residual Disease (MRD) Testing As A Surrogate Endpoint For Multiple Myeloma Clinical Trials

  12/7/2015

• Adaptive Biotech Announces Expansion Of Clonoseq Minimal Residual Disease (MRD) Test

  12/4/2015

• Adaptive Biotech And Collaborators To Present Eleven Studies At American Society of Hematology Annual Meeting

  11/6/2015

• Adaptive Biotech And Collaborators To Present Eleven Studies At American Society of Hematology Annual Meeting

  11/6/2015

• Adaptive Biotech Publishes Study On New Multiplex Technology To Identify Antigen Specificity Of Immune Receptors

  10/28/2015

• Adaptive Biotech Honored By Goldman, Sachs & Co. For Entrepreneurship – Chad And Harlan Robins, Among 100 Most Intriguing Entrepreneurs At 2015 Builders + Innovators Summit

  10/15/2015

• Adaptive Biotech And Collaborators Demonstrate Value Of Immunosequencing For Diagnosis Of Cutaneous T-Cell Lymphoma

  10/8/2015

• Adaptive Biotech Release: World’s Leading Experts To Discuss The Advances Of Immune Profiling In Health And Disease During Unprecedented Conference

  9/10/2015